Zai Lab Ltd (NAS:ZLAB) Stock News, Headlines & Updates
Zai Lab Ltd Stock News from GuruFocus
- 1
Jul 10, 2025
Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025
Business Wire • 7:00am
Zai Lab to Announce Second Quarter 2025 Financial Results and Recent Corporate Updates on August 7, 2025 | ZLAB Stock News
GuruFocus News • 6:46am
Jun 30, 2025
ZLAB Stock: Leerink Partners Raises Price Target for Zai Lab to $75 | ZLAB Stock News
GuruFocus News • 2:00pm
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer
Business Wire • 9:00am
Zai Lab Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-Line Gastric Cancer | ZLAB Stock News
GuruFocus News • 8:17am
Jun 23, 2025
Insider Sell: William Lis Sells 13,814 Shares of Zai Lab Ltd (ZLAB)
GuruFocus News • 5:02pm
Jun 13, 2025
Zai Lab Ltd (ZLAB) Unveils Promising Preclinical Data for ZL-1503 in Atopic Dermatitis Treatment | ZLAB stock news
GuruFocus News • 8:00am
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025
Business Wire • 7:00am
Zai Lab (ZLAB) Reports Promising Preclinical Data for ZL-1503 in Atopic Dermatitis | ZLAB Stock News
GuruFocus News • 6:31am
Zai Lab Presents New Preclinical Data for ZL-1503, an IL-13/IL-31R Bispecific Antibody for the Treatment of Atopic Dermatitis, at EAACI Congress 2025 | ZLAB Stock News
GuruFocus News • 6:16am
Jun 05, 2025
Insider Sell: Yajing Chen Sells 9,618 Shares of Zai Lab Ltd (ZLAB)
GuruFocus News • 7:05pm
Jun 02, 2025
Zai Lab (ZLAB) Presents New Clinical Data for Lung Cancer Treatment | ZLAB Stock News
GuruFocus News • 6:46am
Zai Lab Presents Positive Phase 1 Data for ZL-1310, a DLL3-Targeted ADC, Demonstrating Robust Anti-Tumor Activity and Safety in Patients with Extensive-Stage Small Cell Lung Cancer at 2025 ASCO Annual
GuruFocus News • 6:21am
May 31, 2025
Zai Lab Ltd (ZLAB) Announces Promising Phase 3 Trial Results for Pancreatic Cancer Treatment | ZLAB stock news
GuruFocus News • 3:01pm
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting
Business Wire • 3:00pm
Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting | ZLAB Stock News
GuruFocus News • 2:15pm
May 30, 2025
Zai Lab Ltd (ZLAB) Announces Participation in Key Investor Conferences | ZLAB stock news
GuruFocus News • 7:01am
Zai Lab Announces Participation in Investor Conferences in June 2025
Business Wire • 7:00am
Zai Lab Announces Participation in Investor Conferences in June 2025 | ZLAB Stock News
GuruFocus News • 6:45am
May 19, 2025
Zai Lab Ltd (ZLAB) Receives FDA Fast Track Designation for ZL-1310 in Treating Small Cell Lung Cancer | ZLAB stock news
GuruFocus News • 7:01am
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer
Business Wire • 7:00am
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer | ZLAB Stock News
GuruFocus News • 6:18am
Zai Lab (ZLAB) Gains Fast Track Status for Lung Cancer Drug | ZLAB Stock News
GuruFocus News • 6:17am
May 09, 2025
Zai Lab Ltd (ZLAB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements
GuruFocus News • 1:11am
Decoding Zai Lab Ltd (ZLAB): A Strategic SWOT Insight
GuruFocus News • 11:21pm
Q1 2025 Zai Lab Ltd Earnings Call Transcript
GuruFocus News • 11:15pm
May 08, 2025
Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates
Business Wire • 6:00am
ZLAB's Q1 Revenue Falls Short Amid Global Expansion Efforts | ZLAB Stock News
GuruFocus News • 5:47am
Zai Lab Ltd (ZLAB) Q1 2025 Earnings: EPS Loss of $0.04 Beats Estimate, Revenue of $106.5M Misses Estimate
GuruFocus News • 5:33am
Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates | ZLAB Stock News
GuruFocus News • 5:18am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news